Cathay Biotech Inc (688065) — Financial Flexibility Index
Cathay Biotech Inc (688065) has a Financial Flexibility Index of 0.05x as of September 2025. Free cash flow of CN¥121.64 Million (operating CF CN¥-66.22 Million minus capex CN¥187.86 Million) represents 0% of total liabilities (CN¥2.23 Billion). Check cash flow reinvestment rate of Cathay Biotech Inc to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Cathay Biotech Inc Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for Cathay Biotech Inc across 9 annual periods. For the full cash flow conversion analysis, see Cathay Biotech Inc (688065) cash conversion ratio.
Annual Financial Flexibility Index for Cathay Biotech Inc (2016–2024)
Year-by-year free cash flow to debt coverage for Cathay Biotech Inc. Explore 688065 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.42x | CN¥1.66 Billion | CN¥820.93 Million | CN¥3.92 Billion | ▼ -19.4% |
| 2023 | 0.53x | CN¥2.14 Billion | CN¥569.45 Million | CN¥4.06 Billion | ▼ -70.6% |
| 2022 | 1.79x | CN¥5.00 Billion | CN¥803.67 Million | CN¥2.79 Billion | ▲ +31.0% |
| 2021 | 1.37x | CN¥2.07 Billion | CN¥594.18 Million | CN¥1.51 Billion | ▼ -30.3% |
| 2020 | 1.96x | CN¥1.28 Billion | CN¥514.96 Million | CN¥650.74 Million | ▲ +202.2% |
| 2019 | 0.65x | CN¥870.76 Million | CN¥359.62 Million | CN¥1.34 Billion | ▲ +173.5% |
| 2018 | 0.24x | CN¥399.80 Million | CN¥-10.29 Million | CN¥1.68 Billion | ▼ -78.8% |
| 2017 | 1.12x | CN¥1.05 Billion | CN¥53.45 Million | CN¥936.58 Million | ▲ +152.6% |
| 2016 | 0.44x | CN¥194.67 Million | CN¥-128.67 Million | CN¥439.21 Million | — |